The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea

被引:68
作者
Weil, Gary J. [1 ]
Kastens, Will [2 ]
Susapu, Melinda [3 ]
Laney, Sandra J. [4 ]
Williams, Steven A. [4 ]
King, Christopher L. [2 ]
Kazura, James W. [2 ]
Bockarie, Moses J. [2 ,3 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO 63130 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Papua New Guinea Inst Med Res, Madang, Papua N Guinea
[4] Smith Coll, Northampton, MA 01063 USA
来源
PLOS NEGLECTED TROPICAL DISEASES | 2008年 / 2卷 / 12期
关键词
D O I
10.1371/journal.pntd.0000344
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: This study employed various monitoring methods to assess the impact of repeated rounds of mass drug administration (MDA) on bancroftian filariasis in Papua New Guinea, which has the largest filariasis problem in the Pacific region. Methodology/Principal Findings: Residents of rural villages near Madang were studied prior to and one year after each of three rounds of MDA with diethylcarbamazine plus albendazole administered per World Health Organization (WHO) guidelines. The mean MDA compliance rate was 72.9%. Three rounds of MDA decreased microfilaremia rates (Mf, 1 ml night blood by filter) from 18.6% pre-MDA to 1.3% after the third MDA (a 94% decrease). Mf clearance rates in infected persons were 71%, 90.7%, and 98.1% after 1, 2, and 3 rounds of MDA. Rates of filarial antigenemia assessed by card test (a marker for adult worm infection) decreased from 47.5% to 17.1% (a 64% decrease) after 3 rounds of MDA. The filarial antibody rate (IgG(4) antibodies to Bm14, an indicator of filarial infection status and/or exposure to mosquito-borne infective larvae) decreased from 59.3% to 25.1% (a 54.6% decrease). Mf, antigen, and antibody rates decreased more rapidly in children,11 years of age (by 100%, 84.2%, and 76.8%, respectively) relative to older individuals, perhaps reflecting their lighter infections and shorter durations of exposure/infection prior to MDA. Incidence rates for microfilaremia, filarial antigenemia, and antifilarial antibodies also decreased significantly after MDA. Filarial DNA rates in Anopheles punctulatus mosquitoes that had recently taken a blood meal decreased from 15.1% to 1.0% (a 92.3% decrease). Conclusions/Significance: MDA had dramatic effects on all filariasis parameters in the study area and also reduced incidence rates. Follow-up studies will be needed to determine whether residual infection rates in residents of these villages are sufficient to support sustained transmission by the An. punctulatus vector. Lymphatic filariasis elimination should be feasible in Papua New Guinea if MDA can be effectively delivered to endemic populations.
引用
收藏
页数:7
相关论文
共 38 条
  • [1] [Anonymous], 2000, PREP IMPL NAT PLAN E
  • [2] Lymphatic filariasis in Papua New Guinea: prospects for elimination
    Bockarie, MJ
    Kazura, JW
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2003, 192 (01) : 9 - 14
  • [3] Mass treatment to eliminate filariasis in Papua New Guinea
    Bockarie, MJ
    Tisch, DJ
    Kastens, W
    Alexander, NDE
    Dimber, Z
    Bockarie, F
    Ibam, E
    Alpers, MP
    Kazura, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (23) : 1841 - 1848
  • [4] Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea
    Bockarie, Moses J.
    Tavul, Livingstone
    Ibam, Irvin
    Kastens, Will
    Hazlett, Fred
    Tisch, Daniel J.
    Alpers, Michael P.
    Kazura, James W.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 76 (01) : 62 - 66
  • [6] Evaluation of the ICT whole-blood antigen card test to detect infection due to Wuchereria bancrofti in Sri Lanka
    Chandrasena, TGAN
    Premaratna, R
    Abeyewickrema, W
    de Silva, NR
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2002, 96 (01) : 60 - 63
  • [7] MOLECULAR CLOSING OF BRUGIA-MALAYI ANTIGENS FOR DIAGNOSIS OF LYMPHATIC FILARIASIS
    CHANDRASHEKAR, R
    CURTIS, KC
    RAMZY, RM
    LIFTIS, F
    LI, BW
    WEIL, GJ
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1994, 64 (02) : 261 - 271
  • [8] A MARK RECAPTURE EXPERIMENT WITH THE FILARIASIS VECTOR ANOPHELES-PUNCTULATUS IN PAPUA-NEW-GUINEA
    CHARLWOOD, JD
    BRYAN, JH
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1987, 81 (04): : 429 - 436
  • [9] HYPERENDEMIC BANCROFTIAN FILARIASIS IN KINGDOM OF TONGA - APPLICATION OF MEMBRANE-FILTER CONCENTRATION TECHNIQUE TO AN AGE-STRATIFIED BLOOD SURVEY
    DESOWITZ, RS
    HITCHCOCK, JC
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1974, 23 (05) : 877 - 879
  • [10] A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis
    El Setouhy, M
    Ramzy, RMR
    Ahmed, ES
    Kandil, AM
    Hussain, O
    Farid, HA
    Helmy, H
    Weil, GJ
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 70 (02) : 191 - 196